Huadong Medicine established a medicinal materials company in Wenzhou with a registered capital of 50 million yuan

NightAirdropper · 2026-03-08T02:13:20+00:00

East China Pharmaceutical Raw Materials (Wenzhou) Co., Ltd. was recently established with a registered capital of 50 million yuan. It is wholly owned by East China Pharmaceutical and engages in pharmaceutical wholesale and other businesses. In the first three quarters of 2025, East China Pharmaceutical's operating revenue was 32.664 billion yuan, with a net profit of 2.748 billion yuan, representing growth rates of 3.77% and 7.24%, respectively.

NightAirdropper

2026-03-08 02:13:20

Abstract generation in progress

Rui Cai Jing Liu Zhiying Tianyancha information shows that recently, East China Pharmaceutical Materials (Wenzhou) Co., Ltd. was established. The legal representative is Shen Jianfang, with a registered capital of 50 million yuan. Business scope includes: pharmaceutical wholesale; traditional Chinese medicine decoction piece preparation services; food sales (only pre-packaged foods), etc.

Shareholder information indicates that the company is wholly owned by East China Pharmaceutical (000963).

In the first three quarters of 2025, East China Pharmaceutical achieved operating revenue of 32.664 billion yuan, a year-on-year increase of 3.77%; net profit attributable to the parent was 2.748 billion yuan, up 7.24% year-on-year.

Related company: East China Pharmaceutical sz000963

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes